
Imexpharm’s gross revenue reaches VND 2,118 billion in first nine months
PR Article-Imexpharm reported a 16 per cent year-on-year rise in net revenue to VND 1,800 billion for the first nine months of 2025, with EBITDA margin improving to 22.3 per cent.


















